Shortly after pumping $50M into Indiana site, Catalent will hire up to 600 new employees
Moderna’s vaccine manufacturing partner Catalent has spent all of 2021 capitalizing on the massive demand for vaccine manufacturing and expanding its operations through mergers, acquisitions …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.